trial
as of 2026-07-01Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
NCTId NCT00156715
at a glance
Phase 4 · Completed
Enrollment 23 (actual)
Sponsored by Dartmouth-Hitchcock Medical Center
Primary completion 2006-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
23 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2004-03
Primary completion
2006-09
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Investigators
1
Alan I. Green, MDPrincipal Investigator
Sites
4 total
Augusta, United StatesLebanon, United StatesLebanon, United StatesManchester, United States
Facts & assertions
4 sourced
Enrollment
23
Phase
PHASE4
Primary Completion Date
2006-09
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
company
indication
investigator
person